• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Unique cartilage matrix-associated protein (UCMA)

ACP12716

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP12716 Target NameUCMA
Target SynonymsUCMA; C10orf49; Unique cartilage matrix-associated protein [Cleaved into: Unique cartilage matrix-associated protein C-terminal fragment; Ucma-C; Gla-rich protein; GRP)]FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Expression Range27-138
Protein LengthFull Length of Mature ProteinPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ8WVF2
Background Information
  • Uniprot Id

    Q8WVF2

  • Target Species

    Human

  • Target Name

    UCMA

  • Target Full Name

    Unique cartilage matrix-associated protein

  • Target Function

    May be involved in the negative control of osteogenic differentiation of osteochondrogenic precursor cells in peripheral zones of fetal cartilage and at the cartilage-bone interface.

  • Target Subcellular Location

    Secreted, extracellular space, extracellular matrix.

  • Target Protein Families

    UCMA family

  • Target Tissue Specificity

    Predominantly expressed in resting chondrocytes.

  • Target Synonyms

    UCMA; C10orf49; Unique cartilage matrix-associated protein [Cleaved into: Unique cartilage matrix-associated protein C-terminal fragment; Ucma-C; Gla-rich protein; GRP)]

Inquire Recombinant Human Unique cartilage matrix-associated protein (UCMA) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification